Paul D Drew Selected Research

Paul D Drew Research Topics

Disease

20	Multiple Sclerosis 01/2017 - 03/2002
18	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 03/2002
13	Fetal Alcohol Spectrum Disorders 02/2024 - 06/2011
12	Neuroinflammatory Diseases 01/2023 - 07/2006
9	Inflammation (Inflammations) 01/2023 - 02/2003
5	Autoimmune Diseases (Autoimmune Disease) 04/2011 - 05/2004
3	Alcoholism (Alcohol Abuse) 01/2023 - 11/2016
2	Brain Abscess (Abscess, Brain) 04/2008 - 09/2004
2	Demyelinating Diseases (Demyelinating Disease) 03/2004 - 12/2003
1	Noncommunicable Diseases 03/2024
1	Neurodevelopmental Disorders 01/2023
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2023
1	Teratogenesis 01/2023
1	Cognitive Dysfunction 09/2021
1	Neoplasms (Cancer) 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2012
1	Intellectual Disability (Idiocy) 06/2011
1	Infections 04/2008
1	Abscess 04/2008
1	Encephalomyelitis (Myeloencephalitis) 01/2008
1	Alzheimer Disease (Alzheimer's Disease) 01/2008
1	Hypertriglyceridemia 05/2004
1	Paralysis (Palsy) 12/2003
1	Central Nervous System Diseases (CNS Diseases) 02/2003

Drug/Important Bio-Agent (IBA)

17	Ethanol (Ethyl Alcohol)IBA 03/2024 - 06/2011
10	PPAR-gamma AgonistsIBA 04/2008 - 03/2002
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023 - 09/2004
6	PPAR alphaIBA 04/2009 - 05/2004
6	PPAR gammaIBA 01/2008 - 03/2002
4	CytokinesIBA 08/2014 - 02/2007
4	Interleukin-12 (IL 12)IBA 09/2012 - 02/2007
4	Fenofibrate (CiL)FDA LinkGeneric 12/2007 - 05/2004
3	Pioglitazone (Actos)FDA Link 01/2023 - 03/2015
3	Interleukin-23 (Interleukin 23)IBA 09/2012 - 02/2007
3	Gemfibrozil (Lopid)FDA LinkGeneric 07/2006 - 05/2004
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 01/2009
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021 - 12/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2016 - 03/2006
2	Interleukin-17 (Interleukin 17)IBA 01/2013 - 04/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 04/2005
2	Interleukin-27 (Interleukin 27)IBA 12/2007 - 02/2007
2	ProstaglandinsIBA 04/2005 - 04/2005
2	9-deoxy-delta-9-prostaglandin D2IBA 04/2005 - 09/2004
2	LigandsIBA 03/2004 - 03/2002
1	InflammasomesIBA 03/2024
1	Pattern Recognition ReceptorsIBA 01/2023
1	Chemokine CX3CL1IBA 01/2021
1	CX3C Chemokine Receptor 1IBA 01/2021
1	CC ChemokinesIBA 01/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2017
1	ammonium trichloro(dioxoethylene-O,O'-)tellurate (AS 101)IBA 08/2014
1	Immunologic Factors (Immunomodulators)IBA 08/2014
1	beta-lapachoneIBA 01/2013
1	Quinine (Quinson)FDA Link 01/2013
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2012
1	ResveratrolIBA 09/2012
1	SR1001IBA 04/2011
1	Fibronectins (Fibronectin)IBA 04/2008
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2008
1	ciglitazoneIBA 04/2008
1	Amyloid beta-PeptidesIBA 01/2008
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2006
1	cyclopentenoneIBA 04/2005
1	prostaglandin A2 (PGA2)IBA 04/2005
1	Hormones (Hormone)IBA 04/2005
1	ThiazolidinedionesIBA 04/2005
1	15-deoxyprostaglandin J2IBA 09/2004
1	ciprofibrateIBA 05/2004
1	Retinoid X Receptors (Retinoid X Receptor)IBA 03/2004
1	AntigensIBA 12/2003
1	SteroidsIBA 12/2003

Therapy/Procedure

10	Therapeutics 01/2023 - 12/2003
1	Oral Administration 05/2004